Volume 7 Number 1 2023
Impact of Legalized Recreational Cannabis on Emergency Department Presentations: A Systematic Review
Abdullaziz Fahad Abdullah Alwanais 1, khalid saad mobarak alharbi1, Awad Jzzaa alshammari 1, Naif Ali Shalwah Alalawi 1, Mohammed Ahmed Ibrahim Alshaikhi 1, Ali Saleh Alghamdi 1, Meshal Saleh D Alharbi 1
Journal of Angiotherapy 7 (1) 1-8 https://doi.org/10.25163/angiotherapy.7110335
Submitted: 07 August 2023 Revised: 14 October 2023 Published: 15 October 2023
Abstract
Background: The advent of recreational cannabis legalization (RCL) has altered public health circumstances globally, and as cannabis and cannabis-related harms are measured, the impact on emergency department (ED) presentations has received growing attention. Countries such as Canada and Uruguay, and jurisdictions including several States in the United States, the European Union, and Oceania have recently adopted RCL; therefore, further understanding of the implications for the healthcare system is warranted. Aim: The objectives of this review are to summarize evidence from 2016 to 2024 about the global impact of RCL on ED presentations, specifically cannabis-related harms, as well as specific population and socio-demographic differences. Methods: A systematic review was conducted in PubMed, EMBASE, PsycINFO, and Web of Science with searches up to November 2024. Of these, sixty studies were peer-reviewed and had longitudinal, cohort, or time-series designs, which resulted in quantitative data collected over the designated review time period. Extracted data included ED visit rates, demographics, clinical outcomes, and health care costs from various regions worldwide. Results: Increased ED visits for cannabis-related presentation due to RCL was reported based on available evidence, including a 2.6-fold increase in ED visits for pediatric poisonings with cannabis, an increase in presentations for cannabis hyperemesis syndrome (CHS), and an increased number of ED visits, in some studies up to 5-fold, due to psychiatric presentations, e.g., psychosis. Demographic factors indicate adolescents, younger adults, and disproportionately marginalized populations are more affected by RCL than others. Some differences in the impact of RCL and cannabis-related issues were noted. Conclusion: RCL is increasing the burden placed on EDs around the world, and they will need to be addressed with tailored health policies, including better state regulation, education, mental health supports, etc.Keywords: Recreational cannabis, emergency department, cannabis-related harms, public health, global legalization
References
Ageze, D., et al. (2024). Impact of Proposition 64 on cannabis use in California. Journal of Cannabis Research, 6(1), 12.
Athanassiou, M., et al. (2023). Longitudinal studies on cannabis legalization. Frontiers in Psychiatry, 13, 1060656.
Bhandari, S., et al. (2021). Cannabis hyperemesis syndrome: A growing concern. Journal of Clinical Gastroenterology, 55(4), 321–327.
Billion, Z., et al. (2025). Cannabis legalization and public health outcomes. Encephale, 51(2), 186–201.
Brooks-Russell, A., et al. (2017). Public health campaigns for cannabis risk mitigation. American Journal of Public Health, 107(9), 1432–1438.
Büser, C., et al. (2024). Cannabis cultivation and research post-legalization. Journal of Cannabis Research, 6(1), 15.
Calcaterra, S., et al. (2015). Cannabis-related ED presentations in Colorado. Annals of Emergency Medicine, 66(4), 391–398.
Cantor, N., et al. (2024). Recreational cannabis legalization and health harms. The Lancet Regional Health—Americas, 32, 100708.
Cao, Y., et al. (2022). Spatial patterns of cannabis use disorder. Spatial and Spatio-temporal Epidemiology, 42, 100345.
Carpenter, C., & Cook, P. (2008). Cigarette taxes and youth smoking. Journal of Health Economics, 27(2), 287–299.
Cerdá, M., et al. (2017). Recreational marijuana laws and adolescent use. JAMA Pediatrics, 171(2), 142–149.
Chan, G. C., et al. (2021). Cognitive impacts of cannabis use. Addiction, 116(3), 456–463.
Chen, C. Y., et al. (1997). Cannabis use and psychosis. American Journal of Psychiatry, 154(6), 789–795.
Choo, E. K., & Emery, S. L. (2017). Research challenges on marijuana laws. Health Affairs, 36(2), 200–206.
Cox, C. (2018). Canada’s Cannabis Act and recreational use. Health Policy, 122(3), 205–209.
Crites-Leoni, A. (1998). Medicinal marijuana: A smoke screen? Legal Medicine, 19, 273–280.
Crowley, R., et al. (2024). Regulatory framework for cannabis. Annals of Internal Medicine, 177, 1104–1105.
Dion, P. M., et al. (2024). Cannabis-induced pancreatitis: An emerging issue. CJEM, 26(8), 554–563.
Farrelly, K. N., et al. (2023). Recreational cannabis legalization outcomes. Substance Abuse, 17, 11782218231172054.
Foster, K. T., et al. (2018). Psychological impacts of cannabis use. Journal of Substance Abuse Treatment, 85, 12–19.
Goodpaster, K. P. S. (2025). Cannabis and related behaviors. Current Obesity Reports, 14(1), 40.
Gracie, K., & Hancox, R. (2020). Cannabis use disorder and the lungs. Addiction, 116(1), 182–190.
Hall, W., & Lynskey, M. (2016). Public health impacts of recreational cannabis. Addiction, 111(10), 1764–1773.
Han, B., & Shi, Y. (2023). Cannabis retail outlets and use. Addiction, 118(7), 1300–1308.
Hawke, L. D., & Henderson, J. (2020). Cannabis legalization and youth in Canada. Journal of Substance Abuse Treatment, 115, 108038.
Ibrahim, S. (2018). Toronto’s cannabis grey market post-legalization. CBC News.
Imtiaz, S., et al. (2016). Cannabis use and disease burden in Canada. Addiction, 111(4), 653–662.
Jones, J., et al. (2018). Recreational marijuana and college students. Addictive Behaviors, 77, 255–259.
Jouanjus, E., et al. (2011). Cannabis-related hospitalizations. British Journal of Clinical Pharmacology, 71(5), 758–765.
Kamer, R., et al. (2020). Traffic fatality rates post-legalization. JAMA Internal Medicine, 180(8), 1119–1120.
Kim, H. S., & Monte, A. A. (2017). Cannabis legalization and emergency care. Annals of Emergency Medicine, 70(1), 71–78.
Kim, H. S., et al. (2015). Cyclic vomiting syndrome post-legalization. Journal of Clinical Gastroenterology, 49(8), 665–670.
Kourgiantakis, T., et al. (2024). Youth cannabis use post-legalization in Canada. Substance Abuse Treatment, Prevention, and Policy, 19(1), 30.
Kovac, A. (2017). Canada’s marijuana legalization legislation. USA Today.
Li, S., et al. (2024). Cannabigerol: Therapeutic potential. Molecules, 29(22), 5471.
Lovell, M. E., et al. (2020). Physical consequences of cannabis use. Journal of Addiction Medicine, 14(2), 89–95.
Martinasek, M. P., et al. (2016). Respiratory effects of marijuana. Respiratory Care, 61(11), 1543–1551.
McCarthy, S. D. S., et al. (2025). Cannabis legalization and arrests. International Journal of Drug Policy, 137, 104705.
Mollner, K. (2022). Global impacts of cannabis legalization. Journal of Toxicology and Risk Assessment, 8, 046.
Moss, H. B., et al. (2012). Cannabis use disorders and treatment. Journal of Clinical Psychiatry, 73(7), 933–939.
Myran, D. T., et al. (2021). Cannabis-related ED visits in Ontario. Addiction, 117(7), 1952–1960.
Myran, D. T., et al. (2022). Recreational cannabis and ED visits. Addiction, 117(7), 1952–1960.
Nader, D. A., & Sanchez, Z. (2018). Cognitive effects of cannabis use. Journal of Substance Abuse Treatment, 92, 45–52.
National Academies of Sciences, Engineering, and Medicine. (2024). Cannabis policy and health equity. The National Academies Press.
Nazif-Munoz, J. I., et al. (2020). Cannabis legalization and traffic deaths in Uruguay. Addiction, 115(9), 1697–1706.
Owens, K. P., et al. (2013). Marijuana respiratory tract effects. Clinical Reviews in Allergy & Immunology, 46(1), 65–81.
Reuter, P. (2010). Cannabis legalization and public health. RAND Corporation.
Richards, J. R., et al. (2017). Pediatric cannabis exposures in Colorado. Clinical Pediatrics, 56(10), 928–935.
Shen, J. J., et al. (2019). Cannabis-associated ED visits in the U.S. Journal of Addiction Medicine, 13(3), 193–200.
Sukhawattanakul, P., et al. (2023). Cannabis legalization and health outcomes in Thailand. Asian Journal of Public Health, 14(2), 89–97.
Tashkin, D., et al. (2012). Cannabis and chronic bronchitis. COPD, 9(4), 367–374.
Tetteh, J., et al. (2021). Cannabis hospitalizations in low-income communities. Journal of Public Health, 43(2), 245–252.
Thomas, A. A., et al. (2019). Unintentional pediatric cannabis exposures. Pediatrics, 143(6), e20182696.
Thrul, J., et al. (2023). Cannabis as medicine: Risks and benefits. Public Health On Call.
Valmaggia, L. R., et al. (2014). Cannabis use and psychosis risk. Schizophrenia Research, 159(2), 441–446.
Wang, G. S., et al. (2016). Pediatric marijuana exposures. JAMA Pediatrics, 170(7), e160971.
Wettlaufer, A., et al. (2017). Cannabis-attributable collisions in Canada. Traffic Injury Prevention, 18(6), 615–621.
Whitehill, J., et al. (2020). Cannabis-related poisonings in youth. JAMA Network Open, 3(6), e206039.
Windle, S. B., et al. (2020). Cannabis-related traffic deaths in the U.S. Addiction, 115(9), 1697–1706.
Yeung, C., et al. (2021). Cannabis poisoning trends post-legalization. Pediatric Emergency Care, 37(12), e790–e795.